TrueGenix® Wound & Burn Regenerative Therapy is a Topical Spray Application for Advanced Tissue Support that utilizes stem cell–derived conditioned media to support the body’s natural recovery processes. This advanced formulation is designed for clinical and professional use in the management of burns, wounds, and compromised skin integrity. 
 
Key Features
Supports natural healing and tissue recovery processes
Helps maintain an optimal environment for skin regeneration 
Non-invasive topical spray application
Designed for professional and clinical use
 
Potential Applications
First- and second-degree burns
Chronic wounds, including diabetic ulcers
Post-procedural skin recovery
Pressure ulcers and compromised skin conditions
 
Availability & Regulatory Status
TrueGenix® topical SCCM products, including formulations for skin regeneration, acne & scar care, and neuropathy support, are positioned in accordance with applicable FDA regulatory pathways for cosmetic and/or over-the-counter use in the United States, where appropriate. The Company’s regenerative chronic wound and burn treatment is actively undergoing the FDA approval process, with ongoing clinical and regulatory efforts to support future U.S. commercialization. Preliminary pilot clinical experience has demonstrated encouraging outcomes, with 56 patients treated and no reported adverse effects, and additional studies are planned to further validate safety and efficacy. This advanced wound care therapy is also currently available in select international markets, where permitted.
 
You Can Trust TTrueGenix®
Developed through advanced regenerative science, TrueGenix® products are formulated to meet high standards of quality, consistency, and clinical applicability for professional use.